Watchlist

Watchlist
Adamis Pharmaceuticals Corporation (ADMP)
Adamis Pharmaceuticals Corporation (ADMP)
Biotech Options Traders Are Playing With Fire
The one advantage of playing with fire is that one never gets even singed. It is the people who don't know how to play with it who get burned up. Oscar Wilde Peter Lynch, perhaps the greatest mutual fund manager of all time, has warned about the dangers of options for years…
Can Adamis Bleed Mylan Dry?
Investors and followers of Adamis Pharmaceuticals ( ADMP ) have been desperate for news of a commercial partnership for Symjepi, the company's new competitor to Mylan's ( MYL ) EpiPen. I have been writing about the stock for a while now , and on December 12th I had a fairly lengthy discussion…
Your Daily Pharma Scoop: Gilead's Potential, Celgene CAR-T Candidate, Cellectar Soars
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Total Pharma Tracker subscribers get the full version with actionable ideas one day ea…
Midday Gainers / Losers
Gainers: CUR +101% . RVNC +35% . CLIR +28% . BNED +19% . GLBS +15% . ADMP +13% . GRAM +15% . MBRX +14% . GIII +13% . NES +13% . More news on: Neuralstem, Inc., Revance Therapeutics, Inc., ClearSign Combustion Corp., Stocks on the move, Read more …
Watch These December Biotech Catalysts
December is a month meant to be filled with goodwill, cheer, family harmony, and indulgence in food and drink. Of course, many a Christmas season is also filled with anxiety, enmity, anger, and recrimination. For investors in a few of the most interesting biotech stocks will probably be feelin…
Premarket Gainers as of 9:05 am
SHLD +26% on Q3 earning . More news on: Sears Holdings Corporation, New York & Company, Inc., Adamis Pharmaceuticals Corp., Stocks on the move, Read more …
Your Daily Pharma Scoop: Valeant's B+L In India, TXMD's NDA Resubmission, Melinta Makes An Acquisition
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Valeant B+L This is a tidy little art…
Adamis Pharmaceuticals: A Rocket Still On The Launchpad
Patience is bitter, but its fruit is sweet - Aristotle Investors might be justified in feeling a bit miffed with Adamis Pharmaceuticals ( ADMP ). After winning FDA approval for Symjepi, an epinephrine injector designed to compete with Mylan's ( MYL ) EpiPen (after two false starts than…
Your Daily Pharma Scoop: A Look At Sanofi, Ultragenyx Gets FDA Nod, Capricor Tumbles
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Sanofi Today we will discuss an art…
Biotech Forum Daily Digest: Behind Neurocrine's Big 3rd Quarter Beat
The curious mind embraces science; the gifted and sensitive, the arts; the practical, business; the leftover becomes an economist " - Nassim Nicolaus Taleb It looks like the biotech sector is on its way to posting another down week. The main biotech indices are back down to their levels o…
Adamis Pharmaceuticals: Limited Risk, But Skeptical About Gains
Company Summary Adamis Pharmaceuticals (NASDAQ: ADMP) is a microcap currently valued at about $170M . At the moment, aspires to dethrone the EpiPen with its own allergy symptom (anaphylaxis) treatment called SYMJEPI . The company has several other asthma treatment delivery products in…
Adamis Pharmaceuticals Corporation (ADMP)
Adamis Pharmaceuticals Corporation (ADMP)